‘Self-amplifying’ mRNA COVID shot nears approval in Europe
The European Union's medicine committee has recommended marketing authorization of Kostaive, a self-replicating mRNA injection for COVID-19, despite the fact it has a 90 percent adverse event rate and non-existent long-term safety data.
•
